Effect of glucuronidation substrates/inhibitors on N-(3,5-dichlorophenyl)succinimide nephrotoxicity in Fischer 344 rats.
The agricultural fungicide N-(3,5-dichlorophenyl)succinimide (NDPS) is an acute nephrotoxicant in rats. Our previous studies have strongly suggested that glucuronide conjugation of NDPS metabolites might be a bioactivation step mediating NDPS nephrotoxicity. In this study, effects of substrates and/or inhibitors of primarily glucuronidation on NDPS nephrotoxicity were examined to explore further the role of glucuronidation in NDPS nephrotoxicity. Male Fischer 344 rats (4-6/group) were administered one of the following intraperitoneal (i.p.) pretreatments (dose, pretreatment time) prior to NDPS (0.4 mmol/kg) or NDPS vehicle (sesame oil, 2.5 ml/kg): (1) no pretreatment; (2) borneol (900 mg/kg, 30 min); (3) eugenol (500 mg/kg per day, 3 days); (4) clofibric acid (400 mg/kg, 15 min before (1/2 dose) and 3 h after (1/2 dose)), or (5) valproic acid, sodium salt (1.0 mmol/kg, 15 min). Following NDPS or NDPS vehicle administration, renal function was monitored at 24 and 48 h. Pretreatment with borneol or eugenol, substrates for ether glucuronidation and sulfation (mainly glucuronidation), afforded complete protection against NDPS nephrotoxicity. Substrates for acyl glucuronidation, clofibric acid or valproic acid, mildly reduced or had little effect on NDPS nephrotoxicity, respectively. These results suggest that ether glucuronide conjugates of NDPS metabolites, rather than acyl glucuronide conjugates, may be the primary ultimate nephrotoxicant species mediating NDPS nephrotoxicity.
Hong
S K
SK
Department of Pharmacology, Marshall University School of Medicine, Huntington, WV 25704-9388, USA.
Anestis
D K
DK
Brown
P I
PI
Rankin
G O
GO
D000818:Animals; D001711:Biotransformation; D001806:Blood Urea Nitrogen; D001892:Camphanes / Q000494:pharmacology; D002995:Clofibric Acid / Q000494:pharmacology; D004326:Drinking / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D005054:Eugenol / Q000494:pharmacology; D005659:Fungicides, Industrial / Q000737:chemistry / Q000378:metabolism / Q000633:toxicity*; D005965:Glucuronates / Q000378:metabolism*; D066298:In Vitro Techniques; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D007674:Kidney Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D008297:Male; D009929:Organ Size / Q000187:drug effects; D011507:Proteinuria / Q000139:chemically induced; D051381:Rats; D011916:Rats, Inbred F344; D013388:Succinimides / Q000737:chemistry / Q000378:metabolism / Q000633:toxicity*; D013757:Tetraethylammonium Compounds / Q000378:metabolism; D014635:Valproic Acid / Q000494:pharmacology; D010130:p-Aminohippuric Acid / Q000378:metabolism
D001892:Camphanes; D005659:Fungicides, Industrial; D005965:Glucuronates; D013388:Succinimides; D013757:Tetraethylammonium Compounds; C007352:N-(3,5-dichlorophenyl)succinimide; D005054:Eugenol; D002995:Clofibric Acid; D014635:Valproic Acid; C022871:isoborneol; D010130:p-Aminohippuric Acid